# Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

> **NCT03542916** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 56 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** CJ-40001 60ug
- **DRUG:** NESP 60ug

## Key facts

- **NCT ID:** NCT03542916
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-11
- **Final completion:** 2015-12
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542916, "Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03542916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*